NYSE$AHR

American Healthcare REIT Inc · Q1 2026 earnings

Q1 2026 earnings · · Investor relations

Briefing

American Healthcare REIT reported Q1 2026 total revenues of $650.8M and net income attributable to controlling interest of $23.7M ($0.13 basic EPS).

AHR generated Q1 2026 total revenues of $650.8 million (+20% YoY), split between resident fees ($610M) and real estate revenue ($41M). Net income attributable to controlling interest was $23.7 million versus a $6.8 million loss a year ago; basic EPS was $0.13. Property operating expenses rose with portfolio scale while interest expense was $18.8 million.

  • Total revenues $650.8M (+20%); resident fees $609.8M.
  • Net income to controlling interest $23.7M vs. $(6.8)M prior year.
  • Basic EPS $0.13; NOI drivers include occupancy and rate increases.
  • Property operating expenses $512.2M; depreciation $67.1M.
  • Senior housing/skilled nursing mix per payor tables in filing.

Headline financials

Total Revenue

$651M

Previous: $541M+20.4%
EPS (adj)

$0.13

Previous: -$0.04+425.0%
Capital Expenditures

-$166M

Previous: -$16.4M-909.2%
Net Income

$23.7M

Previous: -$6.8M+448.5%
Operating Income

$126M

Previous: $94.5M+32.8%

Revenue & EPS history

American Healthcare REIT Inc · Revenue · Quarterly

$651M

Q1 2026+20.4%vs Q1 2025
Beat estimate in 3 of 8 quarters(38%)
ActualEstimate

Revenue by segment

American Healthcare REIT Inc · $543M total across 4 segments · Q4 2024

  • ISHC
    $423M
  • SHOP
    $73.5M
  • Outpatient Medical
    $33.3M
  • Triple-Net Leased
    $12.6M

Forward guidance

MD&A cites occupancy gains and billing rate increases in Q1; ATM forward-sale programs noted for capital.

Tailwinds

  • Return to profitability on revenue scale.
  • Occupancy and rate tailwinds in senior housing.
  • Real estate and resident fee growth.

Headwinds

  • High operating and depreciation load.
  • Interest and impairment risk on portfolio.
  • REIT cap rate / labor cost pressure industry-wide.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 11 quarterly earnings reports · overlaid with Q1 2026

Historical avgQ1 2026

+1.8%

Avg return

Earnings day

+2.2%

Avg return

5 days after

+3.9%

Avg return

30 days after

64%

7 / 11 earnings

Positive

+8.3%

Q1 2025

Best reaction

-2.1%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+4.3%+4.1%-4.2%
Q4 2025-2.1%-2.5%-11.4%
Q3 2025+3.0%-0.1%+4.6%
Q2 2025+1.3%+2.0%+7.2%
Q1 2025+8.3%+6.1%+10.2%
Q4 2024-1.3%+0.7%+0.8%
Q3 2024+1.2%+2.7%+7.1%
Q2 2024+3.3%+3.6%+35.1%
Q1 2024-0.1%+3.5%+6.2%
Q2 2023+2.8%+1.3%-6.8%
Q4 2023-0.8%+3.2%-5.9%
Q3 2023
Q1 2023
Q4 2022
Q3 2022
Q2 2022
Q1 2022
Q4 2021
Q3 2021
Q2 2021
Q1 2021
Q4 2020
Q3 2020
Q2 2020
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Q3 2018
Q2 2018
Q1 2018
Q3 2017
Q2 2017
Q1 2017

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro